235 related articles for article (PubMed ID: 21943845)
21. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
22. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.
Haddow LJ; Moosa MY; Mosam A; Moodley P; Parboosing R; Easterbrook PJ
PLoS One; 2012; 7(11):e40623. PubMed ID: 23152745
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D; Marcy O; Madec Y; Chea S; Chan S; Borand L; Fernandez M; Prak N; Kim C; Dim B; Nerrienet E; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
AIDS; 2013 Oct; 27(16):2577-86. PubMed ID: 24096631
[TBL] [Abstract][Full Text] [Related]
24. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
[TBL] [Abstract][Full Text] [Related]
25. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
26. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.
Wang ME; Castillo ME; Montano SM; Zunt JR
Pediatr Infect Dis J; 2009 Oct; 28(10):900-3. PubMed ID: 19687769
[TBL] [Abstract][Full Text] [Related]
27. Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset.
Azzoni L; Barbour R; Papasavvas E; Glencross DK; Stevens WS; Cotton MF; Violari A; Montaner LJ
PLoS One; 2015; 10(12):e0145320. PubMed ID: 26671450
[TBL] [Abstract][Full Text] [Related]
28. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
[TBL] [Abstract][Full Text] [Related]
29. Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.
Puthanakit T; Oberdorfer P; Punjaisee S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Oct; 41(7):1049-52. PubMed ID: 16142674
[TBL] [Abstract][Full Text] [Related]
30. Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial.
Qin Y; Lu Y; Zhou Y; Harypursat V; Sun F; Yang S; Tang S; Li Y; He X; Zeng Y; Chen Y
Trials; 2020 Jun; 21(1):551. PubMed ID: 32571429
[TBL] [Abstract][Full Text] [Related]
31. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
32. Early antiretroviral therapy improves neurodevelopmental outcomes in infants.
Laughton B; Cornell M; Grove D; Kidd M; Springer PE; Dobbels E; van Rensburg AJ; Violari A; Babiker AG; Madhi SA; Jean-Philippe P; Gibb DM; Cotton MF
AIDS; 2012 Aug; 26(13):1685-90. PubMed ID: 22614886
[TBL] [Abstract][Full Text] [Related]
33. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
[TBL] [Abstract][Full Text] [Related]
34. Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients.
Mbandi SK; Painter H; Penn-Nicholson A; Toefy A; Erasmus M; Hanekom WA; Scriba TJ; Lai RPJ; Marais S; Fletcher HA; Meintjes G; Wilkinson RJ; Cotton MF; Pahwa S; Cameron MJ; Nemes E
Eur J Immunol; 2022 Jul; 52(7):1112-1119. PubMed ID: 35398886
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients.
Dibyendu D; Sarkar RN; Phaujdar S; Bhattacharyya K; Pal HK
Braz J Infect Dis; 2011; 15(6):553-9. PubMed ID: 22218514
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries.
Cotton MF; Rabie H; Nemes E; Mujuru H; Bobat R; Njau B; Violari A; Mave V; Mitchell C; Oleske J; Zimmer B; Varghese G; Pahwa S;
PLoS One; 2019; 14(7):e0211155. PubMed ID: 31260455
[TBL] [Abstract][Full Text] [Related]
37. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
[TBL] [Abstract][Full Text] [Related]
39. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.
Grant PM; Komarow L; Andersen J; Sereti I; Pahwa S; Lederman MM; Eron J; Sanne I; Powderly W; Hogg E; Suckow C; Zolopa A
PLoS One; 2010 Jul; 5(7):e11416. PubMed ID: 20617176
[TBL] [Abstract][Full Text] [Related]
40. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
